Publications by authors named "Jackie Walling"

Claim this Profile
B
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.
Morie A Gertz, Adam D Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Jackie Walling

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer.
Linda R Duska, Dmitriy Zamarin, Erica Hamilton, Amit Oza, Gini Fleming, Jackie Walling

JCO Precis Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
Neal D Shore, Fred Saad, Michael S Cookson, Daniel J George, Daniel R Saltzstein, Jackie Walling

N Engl J Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" [Leuk. Res. 50 (Nov) (2016) 123-131. PubMed PMID: 27736729].
Ronan T Swords, Peter L Greenberg, Andrew H Wei, Simon Durrant, Anjali S Advani, Jackie M Walling

Leuk Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study.
Ronan T Swords, Peter L Greenberg, Andrew H Wei, Simon Durrant, Anjali S Advani, Jackie M Walling

Leuk Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction.
Morie A Gertz, Heather Landau, Raymond L Comenzo, David Seldin, Brendan Weiss, Jackie Walling

J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.
Jackie Walling

Invest New Drugs· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.
Clet Niyikiza, Sharyn D Baker, David E Seitz, Jackie M Walling, Katrina Nelson

Mol Cancer Ther· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis